Page 921 - Read Online

Page 18 of 22 Mantovani et al. Hepatoma Res 2020;6:78 I http://dx.doi.org/10.20517/2394-5079.2020.75

38. Almobarak AO, Barakat S, Suliman EA, et al. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese
individuals with type 2 diabetes: Is metabolic syndrome the culprit? Arab J Gastroenterol 2015;16:54-8.
39. Yan LH, Mu B, Guan Y, et al. Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications. J
Diabetes Investig 2016;7:889-94.
40. Alsabaani AA, Mahfouz AA, Awadalla NJ, Musa MJ, Al Humayed SM. Non-Alcoholic fatty liver disease among type-2 diabetes mellitus
patients in abha city, south western saudi arabia. Int J Environ Res Public Health 2018;15:2521.
41. Gutierrez-Buey G, Núñez-Córdoba JM, Llavero-Valero M, Gargallo J, Salvador J, Escalada J. Is HOMA-IR a potential screening test for
non-alcoholic fatty liver disease in adults with type 2 diabetes? Eur J Intern Med 2017;41:74-8.
42. Zawdie B, Tadesse S, Wolide AD, Nigatu TA, Bobasa EM. Non-alcoholic fatty liver disease and associated factors among type 2 diabetic
patients in southwest ethiopia. Ethiop J Health Sci 2018;28:19-30.
43. Dvorak K, Hainer R, Petrtyl J, et al. The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech
Republic. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015;159:442-8.
44. Hua X, Li M, Pan F, Xiao Y, Cui W, Hu Y. Non-alcoholic fatty liver disease is an influencing factor for the association of SHBG with
metabolic syndrome in diabetes patients. Sci Rep 2017;7:14532.
45. Mantovani A, Pernigo M, Bergamini C, et al. Nonalcoholic fatty liver disease is independently associated with early left ventricular
diastolic dysfunction in patients with type 2 diabetes. PLoS One 2015;10:e0135329.
46. Olusanya TO, Lesi OA, Adeyomoye AA, Fasanmade OA. Non alcoholic fatty liver disease in a Nigerian population with type II diabetes
mellitus. Pan Afr Med J 2016;24:20.
47. Chang W, Wang Y, Sun L, Yu D, Li Y, Li G. Evaluation of left atrial function in type 2 diabetes mellitus patients with nonalcoholic fatty
liver disease by two-dimensional speckle tracking echocardiography. Echocardiography 2019;36:1290-7.
48. Zhao CC, Wang AP, Li LX, et al. Urine uric acid excretion is associated with nonalcoholic fatty liver disease in patients with type 2
diabetes. J Diabetes Complications 2016;30:1074-80.
49. Zhang J, Zhang B, Cheng Y, Xu J. Low serum CTRP3 levels are associated with nonalcoholic fatty liver disease in patients with type 2
diabetes mellitus. Cytokine 2018;106:131-5.
50. Johansen ML, Schou M, Rasmussen J, et al. Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty
liver disease in patients with type 2 diabetes. Diabetes Metab 2019;45:429-35.
51. Fan N, Zhang L, Xia Z, Peng L, Wang Y, Peng Y. Sex-specific association between serum uric acid and nonalcoholic fatty liver disease in
type 2 diabetic patients. J Diabetes Res 2016;2016:3805372.
52. García Díaz E, Guagnozzi D, Gutiérrez V, et al. Effect of incretin therapies compared to pioglitazone and gliclazide in non-alcoholic fatty
liver disease in diabetic patients not controlled on metformin alone: An observational, pilot study. Endocrinol Nutr 2016;63:194-201.
53. Demir M, Deyneli O, Yılmaz Y. Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient
elastography study. Turk J Gastroenterol 2019;30:266-70.
54. Petit JM, Masson D, Guiu B, et al. GCKR polymorphism influences liver fat content in patients with type 2 diabetes. Acta Diabetol
2016;53:237-42.
55. Zhao H, Song X, Li Z, Wang X. Risk factors associated with nonalcohol fatty liver disease and fibrosis among patients with type 2
diabetes mellitus. Medicine (Baltimore) 2018;97:e12356.
56. Mantovani A, Rigamonti A, Bonapace S, et al. Nonalcoholic fatty liver disease is associated with ventricular arrhythmias in patients with
type 2 diabetes referred for clinically indicated 24-hour holter monitoring. Diabetes Care 2016;39:1416-23.
57. Barchetta I, Cimini FA, De Gioannis R, et al. Procollagen-III peptide identifies adipose tissue-associated inflammation in type 2 diabetes
with or without nonalcoholic liver disease. Diabetes Metab Res Rev 2018;34:e2998.
58. Choe EY, Lee YH, Choi YJ, et al. Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients
with type 2 diabetes. J Gastroenterol Hepatol 2018;33:1082-91.
59. Silaghi CA, Silaghi H, Crăciun AE, et al. Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in
type 2 diabetes patients with nonalcoholic fatty liver disease. Med Ultrason 2015;17:300-7.
60. Lee H, Kim G, Choi YJ, et al. Association between non-alcoholic steatohepatitis and left ventricular diastolic dysfunction in type 2
diabetes mellitus. Diabetes Metab J 2020;44:267-76.
61. Seo DH, Lee YH, Park SW, et al. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes. Diabetes
Metab 2020;46:362-9.
62. Yeung MW, Wong GL, Choi KC, et al. Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese
patients with type 2 diabetes. J Hepatol 2017:147-56.
63. Bellan M, Colletta C, Barbaglia MN, et al. Severity of nonalcoholic fatty liver disease in type 2 diabetes mellitus: relationship between
nongenetic factors and PNPLA3/HSD17B13 polymorphisms. Diabetes Metab J 2019;43:700-10.
64. Tuong TTK, Tran DK, Phu PQT, Hong TND, Dinh TC, Chu DT. Non-alcoholic fatty liver disease in patients with type 2 diabetes:
evaluation of hepatic fibrosis and steatosis using fibroscan. Diagnostics (Basel) 2020;10:159.
65. Mantovani A, Turino T, Lando MG, et al. Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its
association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes. Diabetes Metab 2020;46:296-
303.
66. Choi DH, Jung CH, Mok JO, Kim CH, Kang SK, Kim BY. Nonalcoholic fatty liver disease and abdominal fat accumulation according to
vitamin d status in patients with type 2 diabetes. J Obes Metab Syndr 2018;27:53-60.
67. Heidari Z, Gharebaghi A. Prevalence of non alcoholic fatty liver disease and its association with diabetic nephropathy in patients with